IXI IXICO plc

0.1712USD13.00 GBp · LSE+1.96%Mkt Cap: 37.49M USDP/E: —

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collectio…

Key Statistics

Company
Market Cap37.49M USD
Enterprise Value14.09M USD
Revenue (TTM)9.58M USD
Gross Profit4.19M USD
Net Income (TTM)-2.17M USD
Revenue/Share0.10 USD
Last Price0.1712 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees79
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB00BFXR4C20
Valuation
P/E (Trailing)—
P/E (Forward)-10.00
PEG—
EV/EBITDA-4.01
EV/Revenue1.47
P/S3.91
P/B1.12
EPS (TTM)-0.03 USD
EPS (Forward)-0.02 USD
52W Range
0.082463% of range0.2239
52W High0.2239 USD
52W Low0.0824 USD
Profitability
Gross Margin48.71%
Oper. Margin-39.40%
EBITDA Margin-36.67%
Profit Margin-25.27%
ROE-14.07%
ROA-11.93%
ROIC-20.24%
ROCE-21.35%
Growth
Revenue Growth23.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.33M USD
CapEx (TTM)1.15M USD
FCF Margin-43.73%
FCF Yield-11.18%
Net Debt-1.47M USD
Net Debt/EBITDA0.42
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio2.83
Quick Ratio2.83
Book Value/Sh0.15 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateSep 4, 2013
Analyst Consensus
Rating—
Target (Mean)0.3424 USD
Upside (mean)+100.0%
Target Range0.3424 USD – 0.3424 USD
# Analysts1
Ownership
Shares Out.218.97M
Float40.77M
Insiders4.55%
Institutions82.55%
Technical
SMA 500.1244 (+37.6%)
SMA 2000.1098 (+56.0%)
Beta-0.03
S&P 52W Chg12.08%
Avg Vol (30d)279.49K
Avg Vol (10d)188.42K
Technical Indicators
RSI (14)65.1
MACD0.9290
MACD Signal1.1576
MACD Hist.-0.2287
BB Upper0.2056 USD
BB Middle0.1684 USD
BB Lower0.1312 USD
BB Width44.18%
ATR (14)0.0155 USD
Vol Ratio (20d)0.36x

About IXICO (LON: IXI)

›

IXICO (LON: IXI) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 79 employees.

The shares were at 13.00 GBp on 19 November 2026, up 20.9% over 52 weeks. Its 52-week range is 6.260 GBp to 17.00 GBp: the price is 23.5% below the high and 107.7% above the low.

Its market capitalisation is 28.47M GBP.

IXICO reports return on equity of -14.1%, an operating margin of -39.4% and revenue up 23.1% year over year.

It holds more cash than debt, a net cash position of 1.12M GBP. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 26.00 GBp is 100.0% above the current price.